Stocks

Are the Markets in Recession Denial?

by Options Sensei

Today saw stocks open deep in the red, only to bounce back and close with back with just minor losses. “Buy the dip” still seems to be the mantra, and still seems to be working. But for how much longer? Today we look at a troubling recession...

Read More

HOLX holds $40

by Christian Tharp, CMT

Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women in the United States, Europe, the Asia-Pacific, and internationally. Take a look at the 1-year chart of Hologic...

Read More

Aimmune Therapeutics (NASDAQ: AIMT)

by Christian Tharp, CMT

Aimmune Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops and commercializes product candidates for the treatment of peanut and other food allergies. Take a look at the 1-year chart of Aimmune (NASDAQ: AIMT) with the...

Read More

Agnico Eagle Mines Ltd (NYSE: AEM)

by Christian Tharp, CMT

Agnico Eagle Mines Limited engages in the exploration, development, and production of mineral properties in Canada, Mexico, and Finland. The company operates through Northern Business and Southern Business segments. Take a look at the 1-year...

Read More

The AAPL 5’s

by Christian Tharp, CMT

Apple Inc. designs, manufactures, and markets mobile communication and media devices, and personal computers to consumers, and small and mid-sized businesses; and education, enterprise, and government customers worldwide. The company also sells...

Read More

PFE Continues to Bounce!

by Christian Tharp, CMT

Pfizer Inc. discovers, develops, manufactures, and sells healthcare products worldwide. It operates in two segments, Pfizer Innovative Health (IH) and Pfizer Essential Health (EH). Take a look at the 1-year chart of Pfizer (NYSE: PFE) below with...

Read More

The Psychology of Money

by Options Sensei

Morgan Housel, of the Collaborative Fund, is one of the best financial writers working today. His latest piece, The Psychology of Money , is nothing short of a tour de force of investing advice. Housel brings his unique insights and...

Read More